Dahl Andrew M. bought EW
November 13, 2025 · Form 4 insider transaction
Dahl Andrew M. bought 1,160 shares of Edwards Lifesciences Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,160
Price
$0.00
Total value
N/A
InsiderDahl Andrew M.
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateNovember 13, 2025
Filing dateNovember 13, 2025
Shares owned after9,183
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These restricted stock units were granted on November 13, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.